Cargando…
Parkinson’s disease between internal medicine and neurology
General medical problems and complications have a major impact on the quality of life in all stages of Parkinson’s disease. To introduce an effective treatment, a comprehensive analysis of the various clinical symptoms must be undertaken. One must distinguish between (1) diseases which arise indepen...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713462/ https://www.ncbi.nlm.nih.gov/pubmed/26298728 http://dx.doi.org/10.1007/s00702-015-1443-z |
_version_ | 1782410182684311552 |
---|---|
author | Csoti, Ilona Jost, Wolfgang H. Reichmann, Heinz |
author_facet | Csoti, Ilona Jost, Wolfgang H. Reichmann, Heinz |
author_sort | Csoti, Ilona |
collection | PubMed |
description | General medical problems and complications have a major impact on the quality of life in all stages of Parkinson’s disease. To introduce an effective treatment, a comprehensive analysis of the various clinical symptoms must be undertaken. One must distinguish between (1) diseases which arise independently of Parkinson’s disease, and (2) diseases which are a direct or indirect consequence of Parkinson’s disease. Medical comorbidity may induce additional limitations to physical strength and coping strategies, and may thus restrict the efficacy of the physical therapy which is essential for treating hypokinetic-rigid symptoms. In selecting the appropriate medication for the treatment of any additional medical symptoms, which may arise, its limitations, contraindications and interactions with dopaminergic substances have to be taken into consideration. General medical symptoms and organ manifestations may also arise as a direct consequence of the autonomic dysfunction associated with Parkinson’s disease. As the disease progresses, additional non-parkinsonian symptoms can be of concern. Furthermore, the side effects of Parkinson medications may necessitate the involvement of other medical specialists. In this review, we will discuss the various general medical aspects of Parkinson’s disease. |
format | Online Article Text |
id | pubmed-4713462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-47134622016-01-22 Parkinson’s disease between internal medicine and neurology Csoti, Ilona Jost, Wolfgang H. Reichmann, Heinz J Neural Transm (Vienna) Neurology and Preclinical Neurological Studies - Review Article General medical problems and complications have a major impact on the quality of life in all stages of Parkinson’s disease. To introduce an effective treatment, a comprehensive analysis of the various clinical symptoms must be undertaken. One must distinguish between (1) diseases which arise independently of Parkinson’s disease, and (2) diseases which are a direct or indirect consequence of Parkinson’s disease. Medical comorbidity may induce additional limitations to physical strength and coping strategies, and may thus restrict the efficacy of the physical therapy which is essential for treating hypokinetic-rigid symptoms. In selecting the appropriate medication for the treatment of any additional medical symptoms, which may arise, its limitations, contraindications and interactions with dopaminergic substances have to be taken into consideration. General medical symptoms and organ manifestations may also arise as a direct consequence of the autonomic dysfunction associated with Parkinson’s disease. As the disease progresses, additional non-parkinsonian symptoms can be of concern. Furthermore, the side effects of Parkinson medications may necessitate the involvement of other medical specialists. In this review, we will discuss the various general medical aspects of Parkinson’s disease. Springer Vienna 2015-08-23 2016 /pmc/articles/PMC4713462/ /pubmed/26298728 http://dx.doi.org/10.1007/s00702-015-1443-z Text en © Springer-Verlag Wien 2015 |
spellingShingle | Neurology and Preclinical Neurological Studies - Review Article Csoti, Ilona Jost, Wolfgang H. Reichmann, Heinz Parkinson’s disease between internal medicine and neurology |
title | Parkinson’s disease between internal medicine and neurology |
title_full | Parkinson’s disease between internal medicine and neurology |
title_fullStr | Parkinson’s disease between internal medicine and neurology |
title_full_unstemmed | Parkinson’s disease between internal medicine and neurology |
title_short | Parkinson’s disease between internal medicine and neurology |
title_sort | parkinson’s disease between internal medicine and neurology |
topic | Neurology and Preclinical Neurological Studies - Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713462/ https://www.ncbi.nlm.nih.gov/pubmed/26298728 http://dx.doi.org/10.1007/s00702-015-1443-z |
work_keys_str_mv | AT csotiilona parkinsonsdiseasebetweeninternalmedicineandneurology AT jostwolfgangh parkinsonsdiseasebetweeninternalmedicineandneurology AT reichmannheinz parkinsonsdiseasebetweeninternalmedicineandneurology |